BBSRC Portfolio Analyser
BBSRC Portfolio Analyser will be decommissioned at the end of 2025.
Other UKRI reporting services are available to you providing details of BBSRC investments:
UKRI - What we have funded
Investigator / Supervisor details
Name
Dr Michael Boursnell
Current Institution
Cantab Pharmaceuticals plc
Current Department
Cantab Pharmaceuticals plc
Previous Institutions
Current Awards
No current BBSRC awards
Completed Awards
Reference
Title
Award Role
Value £
Type
00/A2/P/06094
Herpesvirus envelope proteins and membrane fusion
Co-Supervisor
37,132
Studentships
I accept the
terms and conditions of use
(opens in new window)
export PDF file
back to list
new search